摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

[(N-2-(ethylthio)ethyl-N,N-bis(6-neopentylamino-2-pyridylmethyl)amine)Zn(OH)]ClO4 | 460049-49-4

中文名称
——
中文别名
——
英文名称
[(N-2-(ethylthio)ethyl-N,N-bis(6-neopentylamino-2-pyridylmethyl)amine)Zn(OH)]ClO4
英文别名
——
[(N-2-(ethylthio)ethyl-N,N-bis(6-neopentylamino-2-pyridylmethyl)amine)Zn(OH)]ClO4化学式
CAS
460049-49-4
化学式
C26H44N5OSZn*ClO4
mdl
——
分子量
639.575
InChiKey
IFCOYDLIKMKRQY-UHFFFAOYSA-L
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    None
  • 重原子数:
    None
  • 可旋转键数:
    None
  • 环数:
    None
  • sp3杂化的碳原子比例:
    None
  • 拓扑面积:
    None
  • 氢给体数:
    None
  • 氢受体数:
    None

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Mononuclear Nitrogen/Sulfur-Ligated Zinc Methoxide and Hydroxide Complexes:  Investigating Ligand Effects on the Hydrolytic Stability of Zinc Alkoxide Species
    摘要:
    The synthesis and properties of mononuclear zinc methoxide ([(ebnpa)Zn-OCH3]ClO4) (1) and hydroxide ([(ebnpa)Zn-OH]ClO4) (2) complexes of a new mixed nitrogen/sulfur ligand (ebnpa = N-2-(ethylthio)ethyl-N,N-bis(6-neopentylamino-2-pyridylmethyl)amine) are reported. The structures of 1 and 2 were determined by X-ray diffraction. Each possesses a single zinc-coordinated anion (methoxide or hydroxide) and exhibits an overall trigonal bipyramidal geometry. Structural and spectroscopic studies indicate the presence of two hydrogen-bonding interactions involving the oxygen atom of the zinc-bound anion in each complex. Treatment of [(ebnpa)Zn-OH]ClO4 with CH3OH results in the formation of an equilibrium mixture of 1 and 2. 1H NMR spectroscopic methods were used to examine the equilibrium as a function of temperature, yielding KMe (304 K) = 0.30(8), DeltaHMe = -0.9(1) kcal/mol, and DeltaSMe = -5(1) eu. The negative enthalpy indicates that spontaneous zinc alkoxide formation from a hydroxide precursor occurs in this system at low temperature. Using the experimentally determined DeltaHMe value, we found the homolytic Zn-O bond dissociation energy (BDE) in the Zn-OCH3 unit to be approximately -14 kcal/mol relative to the Zn-O BDE in the Zn-OH unit.
    DOI:
    10.1021/ja0271274
  • 作为产物:
    参考文献:
    名称:
    Mononuclear Nitrogen/Sulfur-Ligated Zinc Methoxide and Hydroxide Complexes:  Investigating Ligand Effects on the Hydrolytic Stability of Zinc Alkoxide Species
    摘要:
    The synthesis and properties of mononuclear zinc methoxide ([(ebnpa)Zn-OCH3]ClO4) (1) and hydroxide ([(ebnpa)Zn-OH]ClO4) (2) complexes of a new mixed nitrogen/sulfur ligand (ebnpa = N-2-(ethylthio)ethyl-N,N-bis(6-neopentylamino-2-pyridylmethyl)amine) are reported. The structures of 1 and 2 were determined by X-ray diffraction. Each possesses a single zinc-coordinated anion (methoxide or hydroxide) and exhibits an overall trigonal bipyramidal geometry. Structural and spectroscopic studies indicate the presence of two hydrogen-bonding interactions involving the oxygen atom of the zinc-bound anion in each complex. Treatment of [(ebnpa)Zn-OH]ClO4 with CH3OH results in the formation of an equilibrium mixture of 1 and 2. 1H NMR spectroscopic methods were used to examine the equilibrium as a function of temperature, yielding KMe (304 K) = 0.30(8), DeltaHMe = -0.9(1) kcal/mol, and DeltaSMe = -5(1) eu. The negative enthalpy indicates that spontaneous zinc alkoxide formation from a hydroxide precursor occurs in this system at low temperature. Using the experimentally determined DeltaHMe value, we found the homolytic Zn-O bond dissociation energy (BDE) in the Zn-OCH3 unit to be approximately -14 kcal/mol relative to the Zn-O BDE in the Zn-OH unit.
    DOI:
    10.1021/ja0271274
点击查看最新优质反应信息

同类化合物

腔肠素HCP 腔肠素F 腔肠素400A 腔肠素-H 腔肠素 恩扎托韦 咪唑并[1.2-b]吡嗪-3-甲酸乙酯 咪唑并[1,2-a]吡嗪-8-胺 咪唑并[1,2-a]吡嗪-6-硫醇 咪唑并[1,2-a]吡嗪-6-甲腈 咪唑并[1,2-a]吡嗪-5(1H)-酮 咪唑并[1,2-a]吡嗪-3-羧酸 咪唑并[1,2-a]吡嗪-3-甲醛 咪唑并[1,2-a]吡嗪-3-基甲醇 咪唑并[1,2-a]吡嗪-2-羧酰胺 咪唑并[1,2-a]吡嗪-2-甲醛 咪唑并[1,2-a]吡嗪-2-甲酸 咪唑并[1,2-a]吡嗪-2-甲腈 咪唑并[1,2-A]吡嗪-3-胺 咪唑并[1,2-A]吡嗪-2-胺 咪唑并[1,2-A]吡嗪-2-羧酸甲酯 咪唑并[1,2-A]吡嗪-2-甲酸乙酯 咪唑并[1,2-A]吡嗪-2-甲胺 吲哚[1,2-A]吡嗪 化合物FURIMAZINE 乙基2-甲基咪唑并[1,2-a]吡嗪-3-羧酸酯 Tirasemtiv(CK-2017357)抑制剂 8-茶碱汞乙酸酯 8-甲氧基咪唑并[1,2-a]吡嗪 8-甲基-2-(三氟甲基)咪唑并[1,2-a]吡嗪 8-溴咪唑并[1,2-a]吡嗪 8-溴-6-甲基咪唑并[1,2-A]吡嗪 8-溴-6-氯咪唑并[1,2-a]吡嗪 8-溴-6-氯-3-甲基咪唑并[1,2-A]吡嗪 8-溴-3-碘咪唑并[1,2-a]吡嗪 8-溴-2-三氟甲基咪唑并[1,2-a]吡嗪 8-氯咪唑并[1,2-a]吡嗪-2-羧酸甲酯 8-氯咪唑并[1,2-a]吡嗪 8-氯-3-碘咪唑并[1,2-a]吡嗪 8-氯-3-甲基咪唑并[1,2-A]吡嗪 8-氯-2-甲基咪唑并[1,2-a]吡嗪 8-氯-2-乙基-咪唑并[1,2-a]吡嗪 8-氯-2-三氟甲基咪唑并[1,2-a]吡嗪 6-甲基咪唑并[1,2-a]吡嗪-2-羧酸 6-甲基-N-苯基咪唑并[1,2-a]吡嗪-3-胺 6-甲基-8-(甲基硫代)-咪唑并[1,2-a]吡嗪 6-溴咪唑并[1,2-a]吡嗪-8-胺 6-溴咪唑并[1,2-a]吡嗪-3-胺 6-溴咪唑并[1,2-a]吡嗪-3-甲醛 6-溴咪唑并[1,2-a]吡嗪-2-胺